Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › HORIZON

HemaFAIR · Fostering F.A.I.R. Data and Standards in Rare Hematological Diseases

HORIZONStatus: SIGNED1 July 202430 June 2027EU funding €1,499,976Call HORIZON-WIDERA-2023-ACCESS-02

Research on rare diseases (RDs) is scarce and fragmented in the EU, leading to delayed diagnoses, limited availability of medicinal products and challenging access to care. Like in most RDs, data-driven research on rare haematological diseases (RHDs) is affected by the lack of data standardisation and the fragmentation of available data in close repositories. Adhering to the principle of making data findable, accessible, interoperable and reusable (FAIR) is pivotal in fostering collaborative research and maximising the potential of available data. FAIR principles are especially relevant in the context of RD research, as their use can help to tackle data fragmentation and accelerate scientific discoveries.HemaFAIR aims to unravel the scientific excellence and innovation potential of a Widening country (Cyprus), through an EU network of excellence on the use of FAIR principles in RHD research. As a reference centre for most RDs in Cyprus, the Cyprus Institute of Neurology & Genetics (CING) can serve as a model for raising the scientific profile and competitiveness of Cyprus in RDs/RHDs and biomedical informatics and strengthening the research management and administrative skills. HemaFAIR brings together key experts in RHD research, biomedical informatics, patient-centred research and ethics and regulatory issues.HemaFAIR will develop and implement a comprehensive training programme and numerous capacity-building and strategic networking activities, including summer schools, workshops, webinars, and transferrable skills lectures. Also, HemaFAIR will raise the profile of early-career researchers via the development of a mentoring programme, short-term staff exchanges and three collaborative research projects. Notably, the research component of HemaFAIR will demonstrate the FAIRification process on two existing platforms for haemoglobinopathies, a group of RHDs that are particularly prevalent in Cyprus, thus maximising the impact of the project on the local society.

Consortium · 5 organisations

coordinator

KYPRIAKO IDRYMA EREVNON GIA TI MYIKI DISTROFIA

CY · €625,625

participant

ACADEMISCH ZIEKENHUIS LEIDEN

NL · €212,500

participant

STICHTING AMSTERDAM UMC

NL · €218,750

participant

FONDAZIONE PER LA RICERCA FARMACOLOGICA GIANNI BENZI ETS

IT · €221,226

participant

FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA

ES · €221,875

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.